| 1 | Bilateral Salpingo-Oophorectomy Is Superior to Salpingectomy Alone in Preventing Non-Tubal Tumor Development in a Mouse Model of High-Grade Serous Carcinoma | 2.7 | 4 | Citations (PDF) |
| 2 | Cell State of Origin Impacts Development of Distinct Endometriosis-Related Ovarian Carcinoma Histotypes | 4.2 | 31 | Citations (PDF) |
| 3 | A putative role for ALDH inhibitors and chemoprevention of BRCA-mutation-driven tumors | 2.3 | 4 | Citations (PDF) |
| 4 | High Prediagnosis Inflammation-Related Risk Score Associated with Decreased Ovarian Cancer Survival | 0.6 | 7 | Citations (PDF) |
| 5 | Endometriosis and menopausal hormone therapy impact the hysterectomy-ovarian cancer association | 2.3 | 13 | Citations (PDF) |
| 6 | Aging accelerates while multiparity delays tumorigenesis in mouse models of high-grade serous carcinoma | 2.3 | 11 | Citations (PDF) |
| 7 | Depot-Medroxyprogesterone Acetate Use Is Associated with Decreased Risk of Ovarian Cancer: The Mounting Evidence of a Protective Role of Progestins | 0.6 | 19 | Citations (PDF) |
| 8 | Altering the Microbiome Inhibits Tumorigenesis in a Mouse Model of Oviductal High-Grade Serous Carcinoma | 4.2 | 42 | Citations (PDF) |
| 9 | Joint IARC/NCI International Cancer Seminar Series Report: expert consensus on future directions for ovarian carcinoma research | 2.2 | 10 | Citations (PDF) |
| 10 | Cervical Mesonephric Adenocarcinoma With Novel FGFR2 Mutation | 1.1 | 7 | Citations (PDF) |
| 11 | Murine Oviductal High-Grade Serous Carcinomas Mirror the Genomic Alterations, Gene Expression Profiles, and Immune Microenvironment of Their Human Counterparts | 4.2 | 27 | Citations (PDF) |
| 12 | Menopausal hormone therapy prior to the diagnosis of ovarian cancer is associated with improved survival | 2.3 | 26 | Citations (PDF) |
| 13 | Epigenetic driver mutations in ARID1A shape cancer immune phenotype and immunotherapy | 6.8 | 177 | Citations (PDF) |
| 14 | Cervical Cancer, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology | 2.8 | 978 | Citations (PDF) |
| 15 | Lineage tracing suggests that ovarian endosalpingiosis does not result from escape of oviductal epithelium | 3.2 | 11 | Citations (PDF) |
| 16 | Trp53 null and R270H mutant alleles have comparable effects in regulating invasion, metastasis, and gene expression in mouse colon tumorigenesis | 1.9 | 29 | Citations (PDF) |
| 17 | Multiclonality and Marked Branched Evolution of Low-Grade Endometrioid Endometrial Carcinoma | 2.6 | 21 | Citations (PDF) |
| 18 | International Society of Gynecological Pathologists (ISGyP) Endometrial Cancer Project: Guidelines From the Special Techniques and Ancillary Studies Group | 1.1 | 68 | Citations (PDF) |
| 19 | Uterine Neoplasms, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology | 2.8 | 581 | Citations (PDF) |
| 20 | The utility of ultrasound superb microvascular imaging for evaluation of breast tumour vascularity: comparison with colour and power Doppler imaging regarding diagnostic performance | 1.1 | 60 | Citations (PDF) |
| 21 | Vulvar Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology | 2.8 | 161 | Citations (PDF) |
| 22 | Of mice and women - Non-ovarian origins of “ovarian” cancer | 2.3 | 15 | Citations (PDF) |
| 23 | High‐grade serous carcinomas arise in the mouse oviduct via defects linked to the human disease | 3.2 | 108 | Citations (PDF) |
| 24 | Preclinical Models of Ovarian Cancer: Pathogenesis, Problems, and Implications for Prevention | 0.8 | 15 | Citations (PDF) |
| 25 | ARID1A-mutated ovarian cancers depend on HDAC6 activity | 12.8 | 216 | Citations (PDF) |
| 26 | Serous Tubal Intraepithelial Carcinoma or Not? Metastases to Fallopian Tube Mucosa Can Masquerade as In Situ Lesions | 1.7 | 25 | Citations (PDF) |
| 27 | New models of hematogenous ovarian cancer metastasis demonstrate preferential spread to the ovary and a requirement for the ovary for abdominal dissemination | 3.6 | 90 | Citations (PDF) |
| 28 | Impact of oviductal versus ovarian epithelial cell of origin on ovarian endometrioid carcinoma phenotype in the mouse | 3.2 | 75 | Citations (PDF) |
| 29 | Arid1a inactivation in an Apc‐ and Pten‐defective mouse ovarian cancer model enhances epithelial differentiation and prolongs survival | 3.2 | 55 | Citations (PDF) |
| 30 | The disparate origins of ovarian cancers: pathogenesis and prevention strategies | 33.8 | 279 | Citations (PDF) |
| 31 | Uterine Sarcoma, Version 1.2016 | 2.8 | 68 | Citations (PDF) |
| 32 | Cervical Cancer, Version 2.2015 | 2.8 | 274 | Citations (PDF) |
| 33 | Microscopic extraovarian sex cord proliferations: an undescribed phenomenon | 2.6 | 30 | Citations (PDF) |
| 34 | Tissue-Specific Effects of Reduced β-catenin Expression on Adenomatous Polyposis Coli Mutation-Instigated Tumorigenesis in Mouse Colon and Ovarian Epithelium | 2.2 | 18 | Citations (PDF) |
| 35 | CD24+ Ovarian Cancer Cells Are Enriched for Cancer-Initiating Cells and Dependent on JAK2 Signaling for Growth and Metastasis | 1.3 | 83 | Citations (PDF) |
| 36 | Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy | 31.3 | 1,145 | Citations (PDF) |
| 37 | HRAS mutations are frequent in inverted urothelial neoplasms | 1.7 | 42 | Citations (PDF) |
| 38 | Uterine Neoplasms, Version 1.2014 | 2.8 | 125 | Citations (PDF) |
| 39 | Myeloid-Derived Suppressor Cells Enhance Stemness of Cancer Cells by Inducing MicroRNA101 and Suppressing the Corepressor CtBP2 | 16.6 | 426 | Citations (PDF) |
| 40 | Type I to Type II Ovarian Carcinoma Progression | 2.8 | 57 | Citations (PDF) |
| 41 | Cervical cancer screening among Michigan women: ‘The Special Cancer Behavioral Risk Factor Survey’, 2004–2008 | 1.2 | 0 | Citations (PDF) |
| 42 | Sox9 Induction, Ectopic Paneth Cells, and Mitotic Spindle Axis Defects in Mouse Colon Adenomatous Epithelium Arising From Conditional Biallelic Apc Inactivation | 2.8 | 95 | Citations (PDF) |
| 43 | Molecular Imaging Reveals a Role for AKT in Resistance to Cisplatin for Ovarian Endometrioid Adenocarcinoma | 4.5 | 20 | Citations (PDF) |
| 44 | Funding Anatomic Pathology Research: A Retrospective Analysis of an Intramural Funding Mechanism | 1.7 | 3 | Citations (PDF) |
| 45 | Two Distinct Categories of Focal Deletions in Cancer Genomes | 1.5 | 37 | Citations (PDF) |
| 46 | A Pilot Study of Microsatellite Instability and Endometrial Cancer Survival in White and African American Women | 1.1 | 5 | Citations (PDF) |
| 47 | Loss of BRCA1-A Complex Function in RAP80 Null Tumor Cells | 1.5 | 12 | Citations (PDF) |
| 48 | Ovarian steroid cell tumor with biallelic adenomatous polyposis coli inactivation in a patient with familial adenomatous polyposis | 1.6 | 15 | Citations (PDF) |
| 49 | Mutant Kras Promotes Hyperplasia and Alters Differentiation in the Colon Epithelium but Does Not Expand the Presumptive Stem Cell Pool | 0.9 | 129 | Citations (PDF) |
| 50 | MSX2 is an oncogenic downstream target of activated WNT signaling in ovarian endometrioid adenocarcinoma | 5.2 | 28 | Citations (PDF) |
| 51 | Human ovarian carcinoma–associated mesenchymal stem cells regulate cancer stem cells and tumorigenesis via altered BMP production | 6.8 | 339 | Citations (PDF) |
| 52 | Preclinical Testing of PI3K/AKT/mTOR Signaling Inhibitors in a Mouse Model of Ovarian Endometrioid Adenocarcinoma | 4.5 | 65 | Citations (PDF) |
| 53 | Mammalian Target of Rapamycin–Dependent Acinar Cell Neoplasia after Inactivation of
Apc
and
Pten
in the Mouse Salivary Gland: Implications for Human Acinic Cell Carcinoma | 4.2 | 46 | Citations (PDF) |
| 54 | IRS1 Regulation by Wnt/β-Catenin Signaling and Varied Contribution of IRS1 to the Neoplastic Phenotype | 1.3 | 56 | Citations (PDF) |
| 55 | COMMD1 disrupts HIF-1α/β dimerization and inhibits human tumor cell invasion | 6.8 | 121 | Citations (PDF) |
| 56 | Loss of Estrogen Receptor 1 Enhances Cervical Cancer Invasion | 2.8 | 66 | Citations (PDF) |
| 57 | Intravascular histiocytosis presenting with extensive vulvar necrosis | 0.7 | 17 | Citations (PDF) |
| 58 | Differential Protein Mapping of Ovarian Serous Adenocarcinomas: Identification of Potential Markers for Distinct Tumor Stage | 2.3 | 36 | Citations (PDF) |
| 59 | Ovarian Cancer | 20.5 | 708 | Citations (PDF) |
| 60 | Ovarian Cancer Update: Lessons From Morphology, Molecules, and Mice | 1.7 | 62 | Citations (PDF) |
| 61 | Comparative proteomic analysis of low stage and high stage endometrioid ovarian adenocarcinomas | 1.5 | 14 | Citations (PDF) |
| 62 | Neurofibromin 1 (NF1) Defects Are Common in Human Ovarian Serous Carcinomas and Co-occur with TP53 Mutations | 2.9 | 81 | Citations (PDF) |
| 63 | Mouse Model of Human Ovarian Endometrioid Adenocarcinoma Based on Somatic Defects in the Wnt/β-Catenin and PI3K/Pten Signaling Pathways | 28.7 | 316 | Citations (PDF) |
| 64 | p53-Mediated Activation of miRNA34 Candidate Tumor-Suppressor Genes | 2.5 | 1,085 | Citations (PDF) |
| 65 | Classifications of ovarian cancer tissues by proteomic patterns | 2.5 | 44 | Citations (PDF) |
| 66 | Classification of Cancer Cell Lines Using an Automated Two-dimensional Liquid Mapping Method with Hierarchical Clustering Techniques | 3.5 | 21 | Citations (PDF) |
| 67 | FGF-20 and DKK1 are transcriptional targets of β-catenin and FGF-20 is implicated in cancer and development | 5.2 | 305 | Citations (PDF) |
| 68 | Title is missing! | 2.5 | 111 | Citations (PDF) |
| 69 | A model-based scan statistic for identifying extreme chromosomal regions of gene expression in human tumors | 3.2 | 30 | Citations (PDF) |
| 70 | Comprehensive proteome analysis of ovarian cancers using liquid phase separation, mass mapping and tandem mass spectrometry: A strategy for identification of candidate cancer biomarkers | 2.5 | 59 | Citations (PDF) |
| 71 | Current challenges and opportunities for research on borderline ovarian tumors | 1.7 | 39 | Citations (PDF) |
| 72 | Remodeling of the extracellular matrix through overexpression of collagen VI contributes to cisplatin resistance in ovarian cancer cells | 28.7 | 326 | Citations (PDF) |
| 73 | Characterization of novel human ovarian cancer-specific transcripts (HOSTs) identified by serial analysis of gene expression | 5.2 | 133 | Citations (PDF) |
| 74 | Accurate Molecular Classification of Human Cancers Based on Gene Expression Using a Simple Classifier with a Pathological Tree-Based Framework | 2.8 | 66 | Citations (PDF) |
| 75 | Amplification and Overexpression of the L-MYC Proto-Oncogene in Ovarian Carcinomas | 2.8 | 67 | Citations (PDF) |
| 76 | Activation of AXIN2 Expression by β-Catenin-T Cell Factor | 1.3 | 346 | Citations (PDF) |
| 77 | A 2-D Liquid Separations/Mass Mapping Method for Interlysate Comparison of Ovarian Cancers | 5.3 | 124 | Citations (PDF) |
| 78 | Role of β-Catenin/T-Cell Factor-Regulated Genes in Ovarian Endometrioid Adenocarcinomas | 2.8 | 101 | Citations (PDF) |
| 79 | CDX2 regulates liver intestine–cadherin expression in normal and malignant colon epithelium and intestinal metaplasia | 0.9 | 202 | Citations (PDF) |
| 80 | ITF-2, a downstream target of the Wnt/TCF pathway, is activated in human cancers with β-catenin defects and promotes neoplastic transformation | 28.7 | 148 | Citations (PDF) |
| 81 | A protein molecular weight map of ES2 clear cell ovarian carcinoma cells using a two-dimensional liquid separations/mass mapping technique | 1.7 | 60 | Citations (PDF) |
| 82 | Glial Implants in Gliomatosis Peritonei Arise from Normal Tissue, Not from the Associated Teratoma | 2.8 | 100 | Citations (PDF) |
| 83 | Organ-Specific Molecular Classification of Primary Lung, Colon, and Ovarian Adenocarcinomas Using Gene Expression Profiles | 2.8 | 182 | Citations (PDF) |
| 84 | Loss of CDX2 Expression and Microsatellite Instability Are Prominent Features of Large Cell Minimally Differentiated Carcinomas of the Colon | 2.8 | 222 | Citations (PDF) |
| 85 | Restored Expression of Fragile Histidine Triad Protein and Tumorigenicity of Cervical Carcinoma Cells | 3.4 | 27 | Citations (PDF) |
| 86 | Somatic Mutations in the STK11/LKB1 Gene Are Uncommon in Rare Gynecological Tumor Types Associated with Peutz-Jegher's Syndrome | 2.8 | 89 | Citations (PDF) |
| 87 | γ-Catenin is regulated by the APC tumor suppressor and its oncogenic activity is distinct from that of β-catenin | 2.9 | 183 | Citations (PDF) |
| 88 | Somatic Mutations of the PPP2R1B Candidate Tumor Suppressor Gene at Chromosome 11q23 are Infrequent in Ovarian Carcinomas | 2.9 | 12 | Citations (PDF) |
| 89 | Atypical immature metaplasia (AIM) of the cervix: Is it related to high-grade squamous intraepithelial lesion (HSIL)?*1 | 1.7 | 60 | Citations (PDF) |
| 90 | Molecular Genetic Evidence Supporting the Clonality and Appendiceal Origin of Pseudomyxoma Peritonei in Women | 2.8 | 249 | Citations (PDF) |
| 91 | Micropapillary Serous Carcinoma of the Ovary | 1.1 | 41 | Citations (PDF) |
| 92 | Reproducibility of the Diagnosis of Endometrial Hyperplasia, Atypical Hyperplasia, and Well-Differentiated Carcinoma | 2.3 | 260 | Citations (PDF) |
| 93 | Human papillomavirus E6 and E7 oncoproteins alter cell cycle progression but not radiosensitivity of carcinoma cells treated with low-dose-rate radiation | 1.4 | 73 | Citations (PDF) |
| 94 | p53 mutations and clonality in vulvar carcinomas and squamous hyperplasias: Evidence suggesting that squamous hyperplasias do not serve as direct precursors of human papillomavirus-negative vulvar carcinomas | 1.7 | 77 | Citations (PDF) |
| 95 | Engineering an intracellular pathway for major histocompatibility complex class II presentation of antigens. | 5.3 | 336 | Citations (PDF) |
| 96 | Frequency of homozygous deletion at p16/CDKN2 in primary human tumours | 14.1 | 610 | Citations (PDF) |
| 97 | 158 Acute dose and low dose-rate irradiation of carcinoma cells expressing human papillomavirus E6 and E7 oncoproteins — The significance of p53, Rb and G1 arrest status | 1.4 | 0 | Citations (PDF) |
| 98 | Functional Consequences of Directed Mutations in Human Papillomavirus E6 Proteins: Abrogation of p53-Mediated Cell Cycle Arrest Correlates with p53 Binding and Degradation in Vitro | 1.6 | 23 | Citations (PDF) |
| 99 | DCC: Linking tumour suppressor genes and altered cell surface interactions in cancer? | 3.5 | 44 | Citations (PDF) |
| 100 | DCC: linking tumor suppressor genes and altered cell surface interactions in cancer? | 2.4 | 68 | Citations (PDF) |
| 101 | NIH3T3 cells expressing the deleted in colorectal cancer tumor suppressor gene product stimulate neurite outgrowth in rat PC12 pheochromocytoma cells | 3.6 | 38 | Citations (PDF) |
| 102 | The DCC gene product in cellular differentiation and colorectal tumorigenesis. | 2.9 | 168 | Citations (PDF) |
| 103 | Expression of a Homologue of the Deleted in Colorectal Cancer (DCC) Gene in the Nervous System of Developing Xenopus Embryos | 1.3 | 38 | Citations (PDF) |
| 104 | The DCC Gene: Structural Analysis and Mutations in Colorectal Carcinomas | 2.0 | 218 | Citations (PDF) |
| 105 | p53-dependent G1 arrest involves pRB-related proteins and is disrupted by the human papillomavirus 16 E7 oncoprotein. | 5.3 | 324 | Citations (PDF) |
| 106 | Cell adhesion molecules as tumour suppressors | 14.2 | 88 | Citations (PDF) |
| 107 | Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage. | 5.3 | 501 | Citations (PDF) |
| 108 | SAM 1.1 and JOSH 4.4: two RFLPs within the human DCC gene | 2.1 | 9 | Citations (PDF) |
| 109 | Antisense RNA to the Putative Tumor Suppressor Gene “Deleted in Colorectal Cancer” Transforms Fibroblasts | 2.6 | 6 | Citations (PDF) |
| 110 | Suppressor gene alterations in the colorectal adenoma-carcinoma sequence | 1.9 | 69 | Citations (PDF) |
| 111 | Genetic alterations in the adenoma–carcinoma sequence | 2.7 | 325 | Citations (PDF) |
| 112 | DCC: A Tumor Suppressor Gene Expressed on the Cell Surface | 1.6 | 29 | Citations (PDF) |
| 113 | Progression of Colorectal Cancer Is Associated with Multiple Tumor Suppressor Gene Defects but Inhibition of Tumorigenicity Is Accomplished by Correction of Any Single Defect via Chromosome Transfer | 1.5 | 76 | Citations (PDF) |
| 114 | Dermatofibrosarcoma protuberans of the vulva | 2.3 | 32 | Citations (PDF) |
| 115 | Scrambled exons | 23.8 | 931 | Citations (PDF) |
| 116 | HindIIIpolymorphism in the DCC gene | 11.2 | 2 | Citations (PDF) |
| 117 | Relationship of severe dysplasia to Stage A (incidental) adenocarcinoma of the prostate | 2.7 | 62 | Citations (PDF) |
| 118 | Relationship of severe dysplasia to Stage B adenocarcinoma of the prostate | 2.7 | 71 | Citations (PDF) |
| 119 | Leiomyoma of the uterus with multiple extrauterine smooth muscle tumors: A case report suggesting multifocal origin | 1.7 | 73 | Citations (PDF) |
| 120 | Lipomeningioma: Report of Three Cases and Review of the Literature | 1.7 | 16 | Citations (PDF) |
| 121 | Malignant Rhabdoid Tumor of the Uterus | 1.1 | 52 | Citations (PDF) |
| 122 | Morphometric Measurement of Tumor Volume and Per Cent of Gland Involvement as Predictors of Pathological Stage in Clinical Stage B Prostate Cancer | 3.3 | 169 | Citations (PDF) |
| 123 | Metastatic Prostatic Carcinoma to Supradiaphragmatic Lymph Nodes | 2.3 | 82 | Citations (PDF) |
| 124 | Transamidation reactions using β-lactams. The synthesis of homaline | 1.0 | 61 | Citations (PDF) |
| 125 | BRAFV600E cooperates with CDX2 inactivation to promote serrated colorectal tumorigenesis | 1.0 | 92 | Citations (PDF) |
| 126 | Title is missing! 0 | | 1 | Citations (PDF) |
| 127 | Medroxyprogesterone Acetate Inhibits Tumorigenesis in Mouse Models of Oviductal High-Grade Serous Carcinoma | 2.7 | 2 | Citations (PDF) |
